Shanghai Boxun Medical Biological Instrument (BJSE:920504) Total Liabilities: ¥54.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920504 Shanghai Boxun Medical Biological Instrument Corp BJSE:920504
69 GF Score
Price ¥17.11
GF Value ¥19.47
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Shanghai Boxun Medical Biological Instrument Total Liabilities?

Shanghai Boxun Medical Biological Instrument BJSE:920504 69 Total Liabilities is ¥54.4 Mil as of Mar. 2026. GuruFocus rates BJSE:920504 with a GF Score™ of 69/100 and a GF Value™ of ¥19.47 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Shanghai Boxun Medical Biological Instrument's Total Liabilities for the quarter that ended in Mar. 2026 was ¥54.4 Mil.

Shanghai Boxun Medical Biological Instrument's quarterly Total Liabilities increased from Sep. 2025 (¥55.00 Mil) to Dec. 2025 (¥64.95 Mil) but then declined from Dec. 2025 (¥64.95 Mil) to Mar. 2026 (¥54.43 Mil).

Shanghai Boxun Medical Biological Instrument's annual Total Liabilities declined from Dec. 2023 (¥74.16 Mil) to Dec. 2024 (¥58.19 Mil) but then increased from Dec. 2024 (¥58.19 Mil) to Dec. 2025 (¥64.95 Mil).

Shanghai Boxun Medical Biological Instrument Total Liabilities Historical Data

* Premium members only.

The historical data trend for Shanghai Boxun Medical Biological Instrument's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Boxun Medical Biological Instrument Total Liabilities Chart

Shanghai Boxun Medical Biological Instrument Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.65 69.85 74.16 58.19 64.95

Shanghai Boxun Medical Biological Instrument Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.04 50.15 55.00 64.95 54.43
BJSE:920504
69GF Score
Shanghai Boxun Medical Biological Instrument Corp BJSE:920504
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Boxun Medical Biological Instrument Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shanghai Boxun Medical Biological Instrument's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=46.212+(16.995+1.746
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=65.0

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=271.36-206.406
=65.0

Shanghai Boxun Medical Biological Instrument's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=35.658+(17.122+1.65
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=54.4

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=262.332-207.902
=54.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ¥54.4 Mil mean?
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a Total Liabilities of ¥54.4 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shanghai Boxun Medical Biological Instrument and its competitors.
Is Shanghai Boxun Medical Biological Instrument's Total Liabilities too high?
Shanghai Boxun Medical Biological Instrument's current Total Liabilities is ¥54.4 Mil. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's Total Liabilities compare to ISRG and BDX?
Shanghai Boxun Medical Biological Instrument's Total Liabilities of ¥54.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shanghai Boxun Medical Biological Instrument and its competitors. Shanghai Boxun Medical Biological Instrument's current Total Liabilities is ¥54.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.47, compared to a current price of ¥17.11 — trading 12.1% below its estimated fair value. The current Total Liabilities is ¥54.4 Mil. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current Total Liabilities is ¥54.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued. The current stock price of ¥17.11 is trading 12.1% below its estimated GF Value™ of ¥19.47. GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Modestly Undervalued.

Key valuation signals for BJSE:920504:

  • Total Liabilities: ¥54.4 Mil
  • GF Value™: ¥19.47 vs. price of ¥17.11 (12.1% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Boxun Medical Biological Instrument Business Description

Address No. 198 Zhongshan North Road, Room 909, Shenhang Building, Jing'an District, Shanghai, CHN, 200071
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score

Get the complete analysis for BJSE:920504

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.11
Price
¥19.47
GF Value